Tower Research Capital (TRC)’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $367K | Buy |
12,768
+12,235
| +2,295% | +$352K | 0.01% | 1238 |
|
2025
Q1 | $17.9K | Sell |
533
-6,879
| -93% | -$231K | ﹤0.01% | 3084 |
|
2024
Q4 | $379K | Buy |
7,412
+6,960
| +1,540% | +$356K | 0.01% | 1251 |
|
2024
Q3 | $23.1K | Sell |
452
-12,404
| -96% | -$634K | ﹤0.01% | 3163 |
|
2024
Q2 | $576K | Buy |
12,856
+12,281
| +2,136% | +$550K | 0.01% | 1223 |
|
2024
Q1 | $26.9K | Sell |
575
-3,028
| -84% | -$142K | ﹤0.01% | 2740 |
|
2023
Q4 | $128K | Buy |
3,603
+2,039
| +130% | +$72.5K | ﹤0.01% | 2442 |
|
2023
Q3 | $46.5K | Sell |
1,564
-2,980
| -66% | -$88.6K | ﹤0.01% | 2608 |
|
2023
Q2 | $81.9K | Buy |
4,544
+2,617
| +136% | +$47.2K | ﹤0.01% | 2173 |
|
2023
Q1 | $31K | Buy |
1,927
+1,009
| +110% | +$16.2K | ﹤0.01% | 2948 |
|
2022
Q4 | $17K | Sell |
918
-9,271
| -91% | -$172K | ﹤0.01% | 3264 |
|
2022
Q3 | $200K | Buy |
10,189
+5,687
| +126% | +$112K | ﹤0.01% | 1928 |
|
2022
Q2 | $84K | Sell |
4,502
-12,242
| -73% | -$228K | ﹤0.01% | 2420 |
|
2022
Q1 | $368K | Buy |
16,744
+13,226
| +376% | +$291K | ﹤0.01% | 1337 |
|
2021
Q4 | $100K | Sell |
3,518
-247
| -7% | -$7.02K | ﹤0.01% | 2220 |
|
2021
Q3 | $79K | Buy |
3,765
+1,881
| +100% | +$39.5K | ﹤0.01% | 2595 |
|
2021
Q2 | $36K | Buy |
1,884
+1,233
| +189% | +$23.6K | ﹤0.01% | 3296 |
|
2021
Q1 | $10K | Sell |
651
-5,422
| -89% | -$83.3K | ﹤0.01% | 4359 |
|
2020
Q4 | $86K | Sell |
6,073
-16,811
| -73% | -$238K | ﹤0.01% | 2495 |
|
2020
Q3 | $359K | Buy |
22,884
+19,582
| +593% | +$307K | ﹤0.01% | 2017 |
|
2020
Q2 | $58K | Buy |
+3,302
| New | +$58K | ﹤0.01% | 2930 |
|
2019
Q4 | – | Sell |
-2,691
| Closed | -$40K | – | 3661 |
|
2019
Q3 | $40K | Buy |
2,691
+2,194
| +441% | +$32.6K | ﹤0.01% | 1955 |
|
2019
Q2 | $12K | Sell |
497
-572
| -54% | -$13.8K | ﹤0.01% | 2448 |
|
2019
Q1 | $24K | Sell |
1,069
-739
| -41% | -$16.6K | ﹤0.01% | 2161 |
|
2018
Q4 | $54K | Buy |
+1,808
| New | +$54K | ﹤0.01% | 1242 |
|